Henry J A, Antao C A
National Poisons Unit, Guys Hospital, London, UK.
Eur J Med. 1992 Oct;1(6):343-8.
To compare the fatal toxicities of antidepressant drugs in England, Scotland and Wales 1985-1989.
Epidemiological retrospective study using Department of Health prescription data and mortality data from the Office of Population Censuses and Surveys, and the Registrar General for Scotland, for the years 1974-1989. The fatal toxicity index (FTI) of groups of drugs and individual drugs was compared with the FTI for all antidepressant drugs for the years 1985-1989.
Of 3,604 single antidepressant deaths between 1975 and 1989, the majority (70.95%) were from amitriptyline or dothiepin. The mean FTI for all drugs for the years 1985-1989 was 35.6; the FTIs for dothiepin, amitriptyline, nortriptyline and tranylcypromine were significantly higher than the mean of all, while those for clomipramine, lofepramine, fluvoxamine, trimipramine, maprotiline, trazodone, mianserin, protriptyline, isocarboxazid and phenelzine were lower. The FTI for the older tricyclic drugs was higher at 43.03 (p < 0.001). The FTI for the monoamine oxidase inhibitors, of 27.03 (p = 0.045), and for all drugs introduced after 1973, of 5.32 (p < 0.001), were each significantly lower than the mean of all drugs.
Overdose deaths from antidepressants have not decreased over the last 15 years. A trend away from prescribing drugs with a higher fatal toxicity index in favour of those with a lower index, would reduce the number of deaths from antidepressant poisoning.
比较1985 - 1989年英格兰、苏格兰和威尔士抗抑郁药物的致命毒性。
采用回顾性流行病学研究,利用卫生部的处方数据以及1974 - 1989年人口普查与调查办公室和苏格兰总登记官的死亡率数据。将各类药物和个别药物的致命毒性指数(FTI)与1985 - 1989年所有抗抑郁药物的FTI进行比较。
在1975年至1989年间的3604例单一抗抑郁药物致死病例中,大多数(70.95%)是由阿米替林或多塞平所致。1985 - 1989年所有药物的平均FTI为35.6;多塞平、阿米替林、去甲替林和反苯环丙胺的FTI显著高于所有药物的平均值,而氯米帕明、洛非帕明、氟伏沙明、曲米帕明、马普替林、曲唑酮、米安色林、普罗替林、异卡波肼和苯乙肼的FTI则较低。 older tricyclic drugs的FTI更高,为43.03(p < 0.001)。单胺氧化酶抑制剂的FTI为27.03(p = 0.045),1973年后引入的所有药物的FTI为5.32(p < 0.001),均显著低于所有药物的平均值。
在过去15年中,抗抑郁药物过量致死情况并未减少。从开具致命毒性指数较高的药物转向开具指数较低的药物,将减少抗抑郁药物中毒死亡人数。